Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor
1998

Oestradiol Regulation of Plasminogen System in Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): AS Levenson, HC Kwaan, KM Svoboda, IM Weiss, S Sakurai, VC Jordan

Primary Institution: Robert H Lurie Cancer Center, Northwestern University Medical School

Hypothesis

How does oestradiol regulate the components of the plasminogen-plasmin system in human breast cancer cells?

Conclusion

Oestradiol down-regulates the expression of uPA, tPA, and PAI-1 in breast cancer cells, which is mediated by the estrogen receptor.

Supporting Evidence

  • Oestradiol treatment resulted in a concentration-dependent decrease in uPA, tPA, and PAI-1 mRNA levels.
  • The anti-oestrogen ICI 182,780 blocked the effects of oestradiol on gene expression.
  • Zymography confirmed the inhibitory effect of oestradiol on uPA activity.

Takeaway

This study found that a hormone called oestradiol can lower the levels of certain proteins that help cancer cells grow and spread.

Methodology

The study used stable transfectants of MDA-MB-231 breast cancer cells to analyze the effects of oestradiol on mRNA and protein levels of plasminogen activators.

Limitations

The model system may not directly replicate the clinical situation in breast cancer.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication